<table border="1"><tr><th>IUPAC nomenclature</th><td><ul><li>5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepine-2-one.</li></ul></td></tr><tr><th>Identity information.</th><td><ul><li>CAS Registry | 1622-61-3 | ATC Code | N03 | AE01 | PubChem | 2802 | Drumbank | DB01068 | ChemSpider | 2700.</li></ul></td></tr><tr><th>chemical properties</th><td><ul><li>chemical formula | C | 15 | H | 10 | Cl | N | 3 | O | 3 | molecular weight | 315.715 | SMILES | eMolecules | &amp; | PubChem</li></ul></td></tr><tr><th>Pharmaceutical Information</th><td><ul><li>Biosynthesis | 90 percent | protein binding | ~85 percent | drug metabolism | liver CYP3A4 | biological sensing | 15 to 50 hours | emission | kidney</li></ul></td></tr><tr><th>Prescription Recommendations</th><td><ul><li>Authorization Information | U.S. Food and Drug Administration | Home Page | Pregnancy Safety | C | (Australia) | D | (U.S.) | Legal Status | Prescription Requirement (S4) | (Australia) | Schedule IV | (Canada) | Class C | (United Kingdom) | Schedule IV | (U.S.) | Adverse Reactions | Middle | Dosage Methods | Oral, Muscle Injection, Bottom Tongue Injection</li></ul></td></tr></table>